These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 16051732)
41. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells. Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965 [TBL] [Abstract][Full Text] [Related]
42. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro. Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848 [TBL] [Abstract][Full Text] [Related]
43. Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation. Yuan CS; Dey L; Wang A; Mehendale S; Xie JT; Aung HH; Ang-Lee MK Planta Med; 2002 Dec; 68(12):1092-6. PubMed ID: 12494336 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Mathews JM; Etheridge AS; Black SR Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118 [TBL] [Abstract][Full Text] [Related]
45. Composition and biological activity of traditional and commercial kava extracts. Côté CS; Kor C; Cohen J; Auclair K Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185 [TBL] [Abstract][Full Text] [Related]
46. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850 [TBL] [Abstract][Full Text] [Related]
47. Analysis of plant extracts by NIRS: simultaneous determination of kavapyrones and water in dry extracts of Piper methysticum Forst. Gaub M; Roeseler Ch; Roos G; Kovar KA J Pharm Biomed Anal; 2004 Nov; 36(4):859-64. PubMed ID: 15533680 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Folmer F; Blasius R; Morceau F; Tabudravu J; Dicato M; Jaspars M; Diederich M Biochem Pharmacol; 2006 Apr; 71(8):1206-18. PubMed ID: 16464438 [TBL] [Abstract][Full Text] [Related]
54. Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro. Tang J; Dunlop RA; Rowe A; Rodgers KJ; Ramzan I Phytother Res; 2011 Mar; 25(3):417-23. PubMed ID: 20734326 [TBL] [Abstract][Full Text] [Related]
55. Protective effect of kava constituents in an in vitro model of oral mucositis. Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894 [TBL] [Abstract][Full Text] [Related]
56. Yangonin, one of the kavalactones isolated from Piper methysticum G. Forst, acts through cannabinoid 1 (CB Chow LH; Lin PC; Chen YJ; Chen YH; Huang EY J Ethnopharmacol; 2024 Oct; 333():118394. PubMed ID: 38823663 [TBL] [Abstract][Full Text] [Related]
57. Hepatocellular toxicity of kava leaf and root extracts. Lüde S; Török M; Dieterle S; Jäggi R; Büter KB; Krähenbühl S Phytomedicine; 2008 Jan; 15(1-2):120-31. PubMed ID: 18055189 [TBL] [Abstract][Full Text] [Related]
58. High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats. Yamazaki Y; Hashida H; Arita A; Hamaguchi K; Shimura F Food Chem Toxicol; 2008 Dec; 46(12):3732-8. PubMed ID: 18930106 [TBL] [Abstract][Full Text] [Related]
59. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. Chua HC; Christensen ET; Hoestgaard-Jensen K; Hartiadi LY; Ramzan I; Jensen AA; Absalom NL; Chebib M PLoS One; 2016; 11(6):e0157700. PubMed ID: 27332705 [TBL] [Abstract][Full Text] [Related]